Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Lumos Pharma

    Client Virtual Booth

    LUMOS PHARMA

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Lumos Pharma
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    4200 Marathon Blvd., Suite 200 Austin, Texas 78756
    Telephone
    Telephone
    (512) 215-2630
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://lumos-pharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/lumos-pharma
    Twitter
    Twitter
    https://twitter.com/lumos_pharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Lumos Pharma Abstracts Accepted At Upcoming Medical Meetings
    Lumos Pharma Abstracts Accepted At Upcoming Medical Meetings

    https://www.globenewswire.com/news-release/2024/04/18/2865819/15114/en/Lumos-Pharma-Announces-Abstracts-Accepted-for-Presentation-at-Upcoming-Medical-Meetings.html

    GLOBENEWSWIRE
    18 Apr 2024
    Share Share
    Lumos Announces that the USPTO Has Granted Patent Novel Formulation of LUM-201
    Lumos Announces that the USPTO Has Granted Patent Novel Formulation of LUM-201

    https://www.globenewswire.com/news-release/2024/03/20/2849307/15114/en/Lumos-Pharma-Announces-that-the-USPTO-Has-Granted-Patent-Protection-for-Novel-Formulation-of-LUM-201-Extending-Exclusivity-to-2042.html

    GLOBENEWSWIRE
    20 Mar 2024
    Share Share
    Lumos Pharma Reports Full Year 2023 Financial Results
    Lumos Pharma Reports Full Year 2023 Financial Results

    https://www.globenewswire.com//news-release/2024/03/07/2842720/15114/en/Lumos-Pharma-Reports-Full-Year-2023-Financial-Results-and-Provides-Clinical-Development-Update.html

    GLOBENEWSWIRE
    07 Mar 2024
    Share Share
    Lumos Pharma to Report Full Year 2023 Financial Results
    Lumos Pharma to Report Full Year 2023 Financial Results

    https://www.globenewswire.com//news-release/2024/02/26/2835146/15114/en/Lumos-Pharma-to-Report-Full-Year-2023-Financial-Results-and-Host-Conference-Call-on-March-7-2024.html

    GLOBENEWSWIRE
    26 Feb 2024
    Share Share
    Lumos Pharma to Participate in Oppenheimer™s 34th Annual Conference
    Lumos Pharma to Participate in Oppenheimer™s 34th Annual Conference

    https://www.globenewswire.com//news-release/2024/02/05/2823843/15114/en/Lumos-Pharma-to-Participate-in-Oppenheimer-s-34th-Annual-Healthcare-Life-Sciences-Conference.html

    GLOBENEWSWIRE
    05 Feb 2024
    Share Share
    Lumos Pharma Promotes Pisit œDuke Pitukcheewanont, MD to Chief Medical Officer
    Lumos Pharma Promotes Pisit œDuke Pitukcheewanont, MD to Chief Medical Officer

    https://www.globenewswire.com//news-release/2024/01/04/2804321/15114/en/Lumos-Pharma-Promotes-Pisit-Duke-Pitukcheewanont-MD-to-Chief-Medical-Officer.html

    GLOBENEWSWIRE
    04 Jan 2024
    Share Share
    Lumos Pharma to Host Virtual Key Opinion Leader Webinar
    Lumos Pharma to Host Virtual Key Opinion Leader Webinar

    https://www.globenewswire.com//news-release/2023/11/21/2784430/15114/en/Lumos-Pharma-to-Host-Virtual-Key-Opinion-Leader-Webinar-to-Discuss-Phase-2-OraGrowtH-Trial-Data-and-Treatment-Potential-of-Oral-LUM-201-for-Pediatric-Growth-Hormone-Deficiency.html

    GLOBENEWSWIRE
    21 Nov 2023
    Share Share
    Lumos Pharma Announces Participation in Piper Sandler 35th Annual Conference
    Lumos Pharma Announces Participation in Piper Sandler 35th Annual Conference

    https://www.globenewswire.com/news-release/2023/11/20/2783597/15114/en/Lumos-Pharma-Announces-Participation-in-the-Piper-Sandler-35th-Annual-Healthcare-Conference-in-November.html

    GLOBENEWSWIRE
    20 Nov 2023
    Share Share
    Lumos stock rockets on oral growth hormone phase 2 results
    Lumos stock rockets on oral growth hormone phase 2 results

    https://www.fiercebiotech.com/biotech/lumos-stock-rockets-phase-2-results-bring-first-oral-growth-hormone-drug-one-step-closer

    James Waldron FIERCE BIOTECH
    08 Nov 2023
    Share Share
    Lumos Pharma Reports Third Quarter 2023 Financial Results
    Lumos Pharma Reports Third Quarter 2023 Financial Results

    https://www.globenewswire.com//news-release/2023/11/07/2775696/15114/en/Lumos-Pharma-Reports-Third-Quarter-2023-Financial-Results-and-Clinical-Development-Updates.html

    GLOBENEWSWIRE
    07 Nov 2023
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search